News

Keep up to date with the latest from Fifth Eye.

After Scoring New Capital, Fifth Eye Prepares to Seek FDA Approval

Fifth Eye’s software is designed to act as an early warning system to predict when a patient might be in imminent trouble, based on their electrocardiogram (ECG) data. When the heart overcompensates for other trouble in the body, the signs are subtle, Baird says, but they have detectable mathematical characteristics, which helps the company’s software to assess the patient’s condition.

Read the full article >

Read More

Fifth Eye Inc. raises $11.5M Series A funding round led by Arboretum Ventures and Cultivation Capital

Fifth Eye uses continuous physiologic waveforms to build clinical early warning systems that enable proactive patient care to improve outcomes, avoid adverse events, shorten lengths of stay and reduce healthcare costs. The financing will be used to secure FDA clearance of Fifth Eye’s first product, support clinical studies with multiple health systems, and enable commercial launch of the company’s first product, the Analytic for Hemodynamic Instability.

Read the full article >

Read More

UM health spinoff Fifth Eye nabs $11 million VC round

“Despite continued advances in healthcare technology, clinicians do not have adequate tools that allow them to consistently identify patients prior to rapid worsening of their clinical condition,” Tom Shehab, a physician and managing partner at Arboretum, told Crain’s. “The Fifth Eye technology has the potential to provide early warning of hemodynamic collapse (and) allows clinicians the opportunity to intervene and improve patient outcomes.”

Read the full article >

Read More

Fifth Eye Scores $2.3M for Software to Detect Patient Warning Signs

Jen Baird, a serial entrepreneur who has led several Michigan-based healthcare technology startups, is back at it with Fifth Eye, an Ann Arbor, MI-based company developing software that performs analytics on patient data. Investors so far like what they see in the young venture: Fifth Eye has just raised $2.3 million in seed funding from Invest Michigan, the Biosciences Research and Commercialization Center at Western Michigan University, and 33 angel investors.

Read the full article >

Read More
  • The key value proposition is in accurately predicting problems before they happen to aid in the  recognition and rescue of the deteriorating patient…this makes it a novel next generation monitoring and predicting tool.

    Critical care/ED MD
  • We have a couple of teams dabbling in "early warning" models but they have not distilled it down to a single ECG lead!

    Chief Medical Officer
  • The linkage of an early response team with this technology would have a very high likelihood of being associated with a significant survival benefit.

    Chief Medical Officer
  • This is an amazing breakthrough!  I can see so many applications within the hospital.  I would like to get you connected to our innovation center so that we could be involved in its development.

    Chair, Vascular Surgery
  • Yes, this is a game-changer. The industry absolutely needs a better detection system for hemodynamic instability.

    Chief Medical Officer
  • All I can say is wow! That is awesome.

    Nurse Trainer